Literature DB >> 24239899

A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye.

Nobuhiro Nagai1, Hirokazu Kaji2, Hideyuki Onami3, Yumi Ishikawa1, Matsuhiko Nishizawa2, Noriko Osumi4, Toru Nakazawa5, Toshiaki Abe6.   

Abstract

The design of drug delivery systems that can deliver multiple drugs to the posterior segment of the eye is a challenging task in retinal disease treatments. We report a polymeric device for multi-drug transscleral delivery at independently controlled release rates. The device comprises a microfabricated reservoir, controlled-release cover and three different fluorescent formulations, which were made of photopolymeized tri(ethyleneglycol)dimethacrylate (TEGDM) and poly(ethyleneglycol)dimethacrylate (PEGDM). The release rate of each fluorescent is controlled by varying the PEGDM/TEGDM ratio in its formulation and the cover. The release kinetics appeared to be related to the swelling ratio of the PEGDM/TEGDM polymers. When the devices were implanted onto rat sclerae, fluorescence was observable in the ocular tissues during 4 weeks' implantation and distributed locally around the implantation site. Our polymeric system, which can administer multiple compounds with distinct kinetics, provides prolonged action and less invasive transscleral administration, and is expected to provide new tools for the treatment of posterior eye diseases with new therapeutic modalities.
Copyright © 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multi-drug delivery; Poly(ethyleneglycol) dimethacrylate; Retina; Transscleral delivery

Mesh:

Substances:

Year:  2013        PMID: 24239899     DOI: 10.1016/j.actbio.2013.11.004

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  6 in total

1.  Physicochemical and biological characterization of sustained isopropyl unoprostone-release device made of poly(ethyleneglycol) dimethacrylates.

Authors:  Nobuhiro Nagai; Yasuko Izumida; Yoshimasa Yamazaki; Hirokazu Kaji; Junichi Kawasaki; Matsuhiko Nishizawa; Toshiaki Abe
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

2.  Controllable continuous sub-tenon drug delivery of dexamethasone disodium phosphate to ocular posterior segment in rabbit.

Authors:  Xuetao Huang; Shaogang Liu; Yezhen Yang; Yiqin Duan; Ding Lin
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice.

Authors:  Cristina García-Caballero; Burke Lieppman; Alicia Arranz-Romera; Irene T Molina-Martínez; Irene Bravo-Osuna; Michael Young; Petr Baranov; Rocío Herrero-Vanrell
Journal:  Mol Vis       Date:  2018-11-16       Impact factor: 2.367

4.  A 3D Printed Self-Sustainable Cell-Encapsulation Drug Delivery Device for Periocular Transplant-Based Treatment of Retinal Degenerative Diseases.

Authors:  Hideto Kojima; Bibek Raut; Li-Jiun Chen; Nobuhiro Nagai; Toshiaki Abe; Hirokazu Kaji
Journal:  Micromachines (Basel)       Date:  2020-04-21       Impact factor: 2.891

Review 5.  Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives.

Authors:  Hyeong Min Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-01-15       Impact factor: 6.321

6.  Application of clotrimazole via a novel controlled release device provides potent retinal protection.

Authors:  Zhaleh Kashkouli Nezhad; Nobuhiro Nagai; Kotaro Yamamoto; Hirokazu Kaji; Matsuhiko Nishizawa; Hideyuki Saya; Toru Nakazawa; Toshiaki Abe
Journal:  J Mater Sci Mater Med       Date:  2015-09-03       Impact factor: 3.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.